Insurance typically covers Mounjaro primarily for patients with an established type 2 diabetes diagnosis
Because the demand has increased so much in the UK, health authorities advised doctors to: Only prioritise those people with type 2 diabetes Avoid prescribing it for weight loss alone This is the reason why many people are not approved for Ozempic at the NHS
To view a copy of this licence, visit About this article Cite this article Duranova, H., Kuzelova, L., Fialkova, V
Lawson et al., 2021
He described the importance of these results: While treatment guidelines for psoriatic arthritis recommend management of obesity, the reality is these two chronic diseases are often addressed separately and moving the needle in psoriatic arthritis has remained challenging, The observed benefit with treatment using Taltz and Zepbound appears to meaningfully impact psoriatic disease activity, indicating that, for many patients, PsA is an obesity-related condition